PyrAmes
Neonatal monitoring company building wireless, noninvasive blood-pressure sensing for NICUs and other acute-care settings.
What They Do
PyrAmes builds Boppli, a wearable blood-pressure monitor designed to give critically ill infants continuous, noninvasive blood-pressure readings without requiring an arterial line. The company positions the product as a safer and simpler alternative to invasive neonatal monitoring, while also developing adjacent platforms for older inpatient and at-home use cases. Public materials suggest a device-first enterprise model selling into hospitals and pediatric care settings rather than a payer-driven service business. Over time PyrAmes appears to want a broader blood-pressure platform, but the neonatal NICU wedge is its clearest point of differentiation today.
Competitive Position
PyrAmes competes with invasive arterial-line monitoring, intermittent cuff-based measurement, and large bedside-monitoring vendors such as GE HealthCare and Philips that are embedded in NICU workflow but do not offer the same noninvasive continuous infant blood-pressure approach. It also overlaps with newer wireless monitoring companies such as sibel-health, though Sibel's current focus is broader multiparameter monitoring rather than blood pressure specifically. PyrAmes differentiates by targeting a very specific neonatal pain point where current standard-of-care methods are either invasive or intermittent.
Funding Rounds
No funding rounds on record for this company.